BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 28681916)

  • 1. Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades.
    Song F; Wei C; Zhou L; Qin A; Yang M; Tickner J; Huang Y; Zhao J; Xu J
    J Cell Physiol; 2018 Feb; 233(2):1723-1735. PubMed ID: 28681916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccarin prevents titanium particle-induced osteolysis and inhibits RANKL-induced osteoclastogenesis by blocking NF-κB and MAPK signaling pathways.
    Liu Y; Song FM; Ma ST; Moro A; Feng WY; Liao SJ; Lin XX; Zhao JM; Wang ZY; Xu J; Zhan XL; Liu Q
    J Cell Physiol; 2019 Aug; 234(8):13832-13842. PubMed ID: 30637734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced Osteolysis.
    Zhu X; Gao J; Ng PY; Qin A; Steer JH; Pavlos NJ; Zheng MH; Dong Y; Cheng TS
    J Bone Miner Res; 2016 Mar; 31(3):560-72. PubMed ID: 26363136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnosol suppresses RANKL-induced osteoclastogenesis and attenuates titanium particles-induced osteolysis.
    Li Y; Lin S; Liu P; Huang J; Qiu J; Wen Z; Yuan J; Qiu H; Liu Y; Liu Q; Zhou T; Luo P; Guo H; Ma Y; Guo D; Mo G; Tang Y; Xu L; Liang D; Xu J; Ding Y; Zhang S
    J Cell Physiol; 2021 Mar; 236(3):1950-1966. PubMed ID: 32722851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geraniin suppresses RANKL-induced osteoclastogenesis in vitro and ameliorates wear particle-induced osteolysis in mouse model.
    Xiao F; Zhai Z; Jiang C; Liu X; Li H; Qu X; Ouyang Z; Fan Q; Tang T; Qin A; Gu D
    Exp Cell Res; 2015 Jan; 330(1):91-101. PubMed ID: 25016282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daphnetin attenuates LPS-induced osteolysis and RANKL mediated osteoclastogenesis through suppression of ERK and NFATc1 pathways.
    Wu Z; Wu H; Li C; Fu F; Ding J; Shao S; Li K; Yu X; Su Y; Liang J; Lin X; Yuan G; Zhou J; Song F; Zhao J; Xu J; Liu Q; Xu F
    J Cell Physiol; 2019 Aug; 234(10):17812-17823. PubMed ID: 30815894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyanidin Chloride inhibits ovariectomy-induced osteoporosis by suppressing RANKL-mediated osteoclastogenesis and associated signaling pathways.
    Cheng J; Zhou L; Liu Q; Tickner J; Tan Z; Li X; Liu M; Lin X; Wang T; Pavlos NJ; Zhao J; Xu J
    J Cell Physiol; 2018 Mar; 233(3):2502-2512. PubMed ID: 28771720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schisantherin A suppresses osteoclast formation and wear particle-induced osteolysis via modulating RANKL signaling pathways.
    He Y; Zhang Q; Shen Y; Chen X; Zhou F; Peng D
    Biochem Biophys Res Commun; 2014 Jul; 449(3):344-50. PubMed ID: 24845381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artesunate inhibits RANKL-induced osteoclastogenesis and bone resorption in vitro and prevents LPS-induced bone loss in vivo.
    Wei CM; Liu Q; Song FM; Lin XX; Su YJ; Xu J; Huang L; Zong SH; Zhao JM
    J Cell Physiol; 2018 Jan; 233(1):476-485. PubMed ID: 28294321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocrotaline Suppresses RANKL-Induced Osteoclastogenesis In Vitro and Prevents LPS-Induced Bone Loss In Vivo.
    Wei CM; Su YJ; Qin X; Ding JX; Liu Q; Song FM; Zong SH; Xu J; Zhou B; Zhao JM
    Cell Physiol Biochem; 2018; 48(2):644-656. PubMed ID: 30025412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sinomenine down-regulates TLR4/TRAF6 expression and attenuates lipopolysaccharide-induced osteoclastogenesis and osteolysis.
    He L; Duan H; Li X; Wang S; Zhang Y; Lei L; Xu J; Liu S; Li X
    Eur J Pharmacol; 2016 May; 779():66-79. PubMed ID: 26965104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling.
    Thummuri D; Jeengar MK; Shrivastava S; Nemani H; Ramavat RN; Chaudhari P; Naidu VG
    Pharmacol Res; 2015 Sep; 99():63-73. PubMed ID: 26022736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stachydrine prevents LPS-induced bone loss by inhibiting osteoclastogenesis via NF-κB and Akt signalling.
    Meng J; Zhou C; Zhang W; Wang W; He B; Hu B; Jiang G; Wang Y; Hong J; Li S; He J; Yan S; Yan W
    J Cell Mol Med; 2019 Oct; 23(10):6730-6743. PubMed ID: 31328430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.
    Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
    Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epothilone B prevents lipopolysaccharide-induced inflammatory osteolysis through suppressing osteoclastogenesis via STAT3 signaling pathway.
    Chen Y; Wang Y; Hu J; Tang Y; Tian Z; Hu W; Zeng F; Tan J; Dai Q; Hou Z; Luo F; Xu J; Dong S
    Aging (Albany NY); 2020 Jun; 12(12):11698-11716. PubMed ID: 32527985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
    Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dehydrocostus lactone attenuates osteoclastogenesis and osteoclast-induced bone loss by modulating NF-κB signalling pathway.
    Hu B; Wu F; Shi Z; He B; Zhao X; Wu H; Yan S
    J Cell Mol Med; 2019 Aug; 23(8):5762-5770. PubMed ID: 31225720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnosol attenuates RANKL-induced osteoclastogenesis in vitro and LPS-induced bone loss.
    Chen Y; Lu J; Li S; Zhang C; Yang Q; Hu B; Zhou C; Hong J; Jiang G; Yan S
    Int Immunopharmacol; 2020 Dec; 89(Pt A):106978. PubMed ID: 33039968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevention of latanoprost on osteoclastgenesis in vitro and lipopolysaccharide-induced murine calvaria osteolysis in vivo.
    Xu X; Yan Y; Liu Z; Qi J; Qian N; Zhou H; Zhou Q; Wang T; Huang P; Guo L; Jiang M; Deng L
    J Cell Biochem; 2018 Jun; 119(6):4680-4691. PubMed ID: 29274286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.